Study

A randomized, double-blind, placebo-controlled crossover study of coenzyme Q10 therapy in hypertensive patients with the metabolic syndrome. – Cost Effective Supplements

A randomized, double-blind, placebo-controlled crossover study of coenzyme Q10 therapy in hypertensive patients with the metabolic syndrome.

Quick navigation


http://www.ncbi.nlm.nih.gov/pubmed/22113168


Conclusion of this study

Although it is possible that coenzyme Q(10) may improve BP control under some circumstances, any effects are likely to be smaller than reported in previous meta-analyses. Furthermore, our data suggest that coenzyme Q(10) is not currently indicated as adjunctive antihypertensive treatment for patients with the metabolic syndrome whose BP control is inadequate, despite regular antihypertensive therapy.


Supplements analyzed in this study

Coenzyme Q10

Health conditions analyzed in this study

No health conditions information for this study.

Functions related to this study

Heart health


Slightly Positive
Coenzyme Q10


Body systems related to this study


Cardiovascular System
Scroll to top